Pharma News

Researchers are developing a new drug that may prevent the onset of diabetes and reverse the symptoms of the disease.

Scientists have managed to prolong the lifespan of flies by up to 60 per cent after activating a gene which destroys unhealthy cells, an advance which may help develop new anti-ageing treatments for humans.

The U.S. Food and Drug Administration today approved Avycaz (ceftazidime-avibactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI), in combination with metronidazole, and complicated urinary tract infections (cUTI), including kidney infections (pyelonephritis), who have limited or no alternative treatment options.

A new mobile app developed by an Indian-origin scientist allows your smartphone to help conduct research on breast cancer and Alzheimer’s while the device is at rest and charging. The Folding@home mobile app is an extension of the Folding@home distributed computing project launched by Vijay Pande, a professor of chemistry at Stanford University, in collaboration with Japanese corporate giant Sony in 2007.

Researchers are developing an electric retainer that could allow the hearing-impaired to ‘listen’ through their tongues. The retainer will eliminate the need for expensive cochlear implants for those with hearing loss, researchers said.

Worldwide spending on cancer has reached levels equivalent to the GDP of Hong Kong which is the 35^th largest economy in the world, a new report to be presented at a global health summit in Qatar later this month has claimed.

The Union Minister of Chemicals & Fertilizers Sh. Ananth Kumar has assured the Pharmaceutical Industry that appropriate decisions will be taken soon so that India becomes self-sufficient in the Bulk Drugs. At the launch ceremony of “2015 – Year of Active Pharmaceutical Ingredients” the Government is committed to usher in reforms and good governance, and promote the concept of “Make in India”, said Ananth Kumar.

[adsense:336x280:8701650588]

Need for high investment, lack of necessary facilities and the complex nature of the virus make the finding of a vaccine for Ebola a difficult challenge, a noted French microbiologist said here today. "Developing a vaccine is not a trivial issue. It requires huge investments by pharmaceutical companies. So far, Ebola has had limited outbreaks. So there was no need for the community to be convinced that there has to be a vaccine.